SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid escalating Middle East tensions driving a significant surge in oil prices and prompting global market jitters, with the community widely debating if the market faces a major crash or presents a generational buying opportunity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is experiencing significant bearish sentiment as escalating Middle East tensions drive oil prices sharply higher, prompting widespread community discussion of a potential "Black Monday" and a major downturn for tech and growth stocks.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as escalating Middle East conflict, including Israeli strikes on Iranian oil facilities and Strait of Hormuz disruptions, drives crude prices past $100. The community is sharply divided, with bulls celebrating massive gains and anticipating further spikes, while bears view the surge as a "manufactured move" or "bull trap" amidst broader market concerns.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending due to rapidly escalating geopolitical tensions driving crude oil prices significantly higher, sparking significant community chatter about a massive short squeeze. Traders are closely watching for a strong price breakout, drawing comparisons to the stock's parabolic ascent during previous oil spikes.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as community discussion intensifies around escalating geopolitical tensions, with many expressing concern over surging oil prices and potential market instability stemming from the administration's actions in Iran, contrasting sharply with some unwavering support for the political figure.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the market keenly awaits an imminent regulatory report on its autonomous driving safety, a pivotal moment for its robotaxi future. This comes amidst rising global oil prices, prompting community discussion on whether this will drive EV adoption despite widespread market caution and ongoing debate over Tesla's valuation and slowing sales.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The biotech community is highly anticipating SLS's Phase 3 results for its GPS immunotherapy, with recent CEO comments on "curative outcomes" in AML fueling speculation about groundbreaking efficacy and an imminent buyout, despite significant short interest.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

SCO is trending as the community aggressively accumulates this inverse crude oil ETF, betting on an eventual significant pullback in oil prices from current levels despite ongoing Middle East geopolitical tensions. Traders are actively shorting crude, viewing recent spikes as opportunities to build bearish positions amidst concerns of potential oversupply.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is trending as crude oil prices surge due to escalating Middle East tensions and disruptions to oil infrastructure, with the community actively anticipating a short squeeze and further parabolic moves for this low-float energy play. Traders are positioning for significant upside, drawing parallels to other oil stocks benefiting from global supply concerns.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF is experiencing extreme volatility as escalating US-Iran tensions and surging oil prices fuel fears of a broader market downturn, sparking intense community debate between predictions of a "Black Monday" and hopes for a quick rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Issues Positive Outlook for TCRX Earnings

TScan Therapeutics, Inc. (NASDAQ:TCRX - Free Report) - HC Wainwright raised their Q1 2026 earnings estimates for TScan Therapeutics in a research note issued on Wednesday, March 4th. HC Wainwright...

FY2030 Earnings Estimate for TCRX Issued By HC Wainwright

TScan Therapeutics, Inc. (NASDAQ:TCRX - Free Report) - Equities research analysts at HC Wainwright issued their FY2030 EPS estimates for shares of TScan Therapeutics in a note issued to investors on...

TScan Therapeutics (NASDAQ:TCRX) Price Target Raised to $5.00

Wedbush lifted their price target on TScan Therapeutics from $4.00 to $5.00 and gave the stock an "outperform" rating in a research note on Thursday...

TScan Therapeutics (NASDAQ:TCRX) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS

TScan Therapeutics (NASDAQ:TCRX - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.18) earnings per share for the quarter, beating the consensus estimate...

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates

TScan Therapeutics (TCRX) delivered earnings and revenue surprises of +34.31% and -37.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Breakdown: TScan Therapeutics Q4

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates

Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of +24.11% and +39.36%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

TScan Therapeutics (TCRX) Projected to Post Quarterly Earnings on Wednesday

TScan Therapeutics (NASDAQ:TCRX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 4. (View Earnings Report at...

TScan Therapeutics (NASDAQ:TCRX) Trading Up 4.6% - Here's What Happened

TScan Therapeutics (NASDAQ:TCRX) Shares Up 4.6% - Here's Why...

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of "Hold" from Brokerages

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) has received an average rating of "Hold" from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. One...

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.

TCRX
Tscan Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TCRX News

TCRXTscan Therapeutics Inc